Detalhe da pesquisa
1.
Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation.
Immunology
; 172(1): 109-126, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38316548
2.
Dysregulation of B lymphocyte development in the SKG mouse model of rheumatoid arthritis.
Immunology
; 170(4): 553-566, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688495
3.
Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma.
J Cell Mol Med
; 25(14): 7089-7094, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114734
4.
B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1.
Front Immunol
; 15: 1353138, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529289
5.
Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
Sci Rep
; 13(1): 338, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611064
6.
p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress.
Cell Death Dis
; 12(10): 923, 2021 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625535
7.
Glutathione Metabolism Is a Regulator of the Acute Inflammatory Response of Monocytes to (1â3)-ß-D-Glucan.
Front Immunol
; 12: 694152, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34858388
8.
Regulation of B Lymphocyte Development by Histone H2A Deubiquitinase BAP1.
Front Immunol
; 12: 626418, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912157